The global allergy diagnostics market is expected to reach USD 5.74 Billion by 2022 from USD 3.49 Billion in 2017, at a CAGR of 10.5%. Geographically, the allergy diagnostics market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW).
Download Brochure Now at Allergy Diagnostics Market spread across 149 Pages, Profiling 11 Companies and Supported with 105 Tables and 32 Figures is now available at www.reportsnreports.com/contacts/r….aspx?name=320079 .
Allergy diagnostics market is segmented into inhaled allergens, food allergens, drug allergens, and other allergens. In 2017, inhaled allergens segment is expected to account for the largest share of the allergy diagnostics market.
Increasing environmental pollution is one of the major factors driving the growth of this segment.
Assay kits segment is expected to lead the global allergy diagnostics market in 2017.
Key Target Audience for this Report:
- Allergy diagnostics reagents, kits, and instruments manufacturers
- Allergy diagnostics vendors and distributors
- Diagnostic laboratories
- Allergy diagnostic service providers
- Academic research institutes
- Venture capitalists and investors
- Research institutes and clinical research organizations (CROs)
- Government associations
The global allergy diagnostics market is segmented by product & service, test type, allergen, end user, and region. By product & service, the allergy diagnostics market is segmented into assay kits, instruments, and services.
The assay kits segment is expected to lead the global allergy diagnostics market in 2017. The widespread availability and large consumption of assay kits in allergy testing are expected to drive the growth of this segment in the coming years.
Interested in this New Research Study Click Now for More Information with Top Trends is Available Now www.reportsnreports.com/contacts/i….aspx?name=320079 .
In addition, allergy diagnostics market company profiles comprise product portfolios, developments, and strategies adopted by market players to maintain & increase their shares in market. Report analyses allergy diagnostics market by product and service, test, allergen, end user, & region.
Asian region is estimated to grow at the fastest rate which can be attributed to the improving life sciences research infrastructure in emerging economies and rising investments by governments to promote research activities. The global allergy diagnostics market is segmented by product & service, test type, allergen, end user, and region.
1 Allergy Diagnostics: Market Overview
2 Allergy Diagnostics Market, By Allergens (2017)
3 Geographic Snapshot of the Allergy Diagnostics Market
4 Allergy Diagnostics Market, By Test Type, 2017 vs 2022
Click now for more Details, Quiries, Other Information on this study “Allergy Diagnostics Market by Products (Assay Kits, Immunoassay & Elisa Analyzers, Luminometers, Services), Allergens (Food, Inhaled, Drug), Tests (In Vivo, In Vitro), End Users (Hospital, Diagnostic Laboratory) - Global Forecast to 2022” report @ www.reportsnreports.com/contacts/d….aspx?name=320079 .
The key players in the allergy diagnostics market include Thermo Fisher Scientific Inc. (US), Siemens AG (Germany), Danaher Corporation (US),Omega Diagnostics Group PLC (UK), Hitachi Chemical Co., Ltd.
(Japan), bioMérieux SA (France), Stallergenes Greer (UK), HOB Biotech Group Suzhou Co., Ltd. (China), HYCOR Biomedical (US), Lincoln Diagnostics, Inc.
(US), EUROIMMUN AG (Germany), INDOOR Biotechnologies, Inc. (US), DR. FOOKE - Achterrath Laboratorien GmbH (Germany), R-Biopharm AG (Germany), GA Generic Assays GmbH (Germany), Tecan Trading AG (Switzerland), DST Diagnostische Systeme & Technologien GmbH (Germany), ROXALL Medical GmbH (Germany), ALK-Abelló A/S (Denmark), Angsana Molecular & Diagnostics Laboratory Pte Ltd.
(Singapore), Allergy Therapeutics (UK), HAL Allergy Group (Netherlands), Theradiag (France), Allergy Therapeutics (UK), Astra Biotech GmbH (Germany), and Demeditec Diagnostics GmbH (Germany).